Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements

Michael Kosicki; Kärt Tomberg; Allan Bradley

doi:10.1038/nbt.4192

journal article Jul 16, 2018

Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements

Michael Kosicki Kärt Tomberg Allan Bradley

Nature Biotechnology Vol. 36 No. 8 pp. 765-771 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nbt.4192

Topics

No keywords indexed for this article. Browse by subject →

References

38

[1]

Cornu, T.I., Mussolino, C. & Cathomen, T. Refining strategies to translate genome editing to the clinic. Nat. Med. 23, 415–423 (2017). 10.1038/nm.4313

[2]

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins

Sojung Kim, Daesik Kim, Seung Woo Cho et al.

Genome Research 2014 10.1101/gr.171322.113

[3]

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Alexis C. Komor, Yongjoo B. Kim, Michael S. Packer et al.

Nature 2016 10.1038/nature17946

[4]

Frock, R.L. et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 33, 179–186 (2015). 10.1038/nbt.3101

[5]

Xie, F. et al. Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res. 24, 1526–1533 (2014). 10.1101/gr.173427.114

[6]

Guilinger, J.P., Thompson, D.B. & Liu, D.R. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat. Biotechnol. 32, 577–582 (2014). 10.1038/nbt.2909

[7]

High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects

Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew et al.

Nature 2016 10.1038/nature16526

[8]

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

F. Ann Ran, Patrick D. Hsu, Chie-Yu Lin et al.

Cell 2013 10.1016/j.cell.2013.08.021

[9]

Rationally engineered Cas9 nucleases with improved specificity

Ian M. Slaymaker, Linyi Gao, Bernd Zetsche et al.

Science 2016 10.1126/science.aad5227

[10]

Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing

Shengdar Q Tsai, Nicolas Wyvekens, Cyd Khayter et al.

Nature Biotechnology 2014 10.1038/nbt.2908

[11]

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

Yanfang Fu, Jennifer A Foden, Cyd Khayter et al.

Nature Biotechnology 2013 10.1038/nbt.2623

[12]

Tsai, S.Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187–197 (2015). 10.1038/nbt.3117

[13]

Koike-Yusa, H., Li, Y., Tan, E.-P. & Velasco-Herrera, M.D.C. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267–273 (2014). 10.1038/nbt.2800

[14]

van Overbeek, M. et al. DNA repair profiling reveals nonrandom outcomes at Cas9-mediated breaks. Mol. Cell 63, 633–646 (2016). 10.1016/j.molcel.2016.06.037

[15]

Tan, E.P., Li, Y., Velasco-Herrera, M.D.C., Yusa, K. & Bradley, A. Off-target assessment of CRISPR-Cas9 guiding RNAs in human iPS and mouse ES cells. Genesis 53, 225–236 (2015). 10.1002/dvg.22835

[16]

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells

Ayal Hendel, Rasmus O Bak, Joseph T Clark et al.

Nature Biotechnology 2015 10.1038/nbt.3290

[17]

Ghezraoui, H. et al. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol. Cell 55, 829–842 (2014). 10.1016/j.molcel.2014.08.002

[18]

Weinstock, D.M., Elliott, B. & Jasin, M. A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 107, 777–780 (2006). 10.1182/blood-2005-06-2437

[19]

Canver, M.C. et al. Characterization of genomic deletion efficiency mediated by CRISPR/Cas9 in mammalian cells. J. Biol. Chem. 289, 21312–21324 (2014). 10.1074/jbc.m114.564625

[20]

Kraft, K. et al. Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice. Cell Rep. 10, 833–839 (2015). 10.1016/j.celrep.2015.01.016

[21]

Boroviak, K., Doe, B., Banerjee, R., Yang, F. & Bradley, A. Chromosome engineering in zygotes with CRISPR/Cas9. Genesis 54, 78–85 (2016). 10.1002/dvg.22915

[22]

Boroviak, K., Fu, B., Yang, F., Doe, B. & Bradley, A. Revealing hidden complexities of genomic rearrangements generated with Cas9. Sci. Rep. 7, 12867 (2017). 10.1038/s41598-017-12740-6

[23]

Parikh, B.A., Beckman, D.L., Patel, S.J., White, J.M. & Yokoyama, W.M. Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One 10, e0116484 (2015). 10.1371/journal.pone.0116484

[24]

Shin, H.Y. et al. CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017). 10.1038/ncomms15464

[25]

Gasperini, M. et al. CRISPR/Cas9-mediated scanning for regulatory elements required for HPRT1 expression via thousands of large, programmed genomic deletions. Am. J. Hum. Genet. 101, 192–205 (2017). 10.1016/j.ajhg.2017.06.010

[26]

Roberts, S.A. et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424–435 (2012). 10.1016/j.molcel.2012.03.030

[27]

Sinha, S. et al. Microhomology-mediated end joining induces hypermutagenesis at breakpoint junctions. PLoS Genet. 13, e1006714 (2017). 10.1371/journal.pgen.1006714

[28]

Yang, Y., Sterling, J., Storici, F., Resnick, M.A. & Gordenin, D.A. Hypermutability of damaged single-strand DNA formed at double-strand breaks and uncapped telomeres in yeast Saccharomyces cerevisiae. PLoS Genet. 4, e1000264 (2008). 10.1371/journal.pgen.1000264

[29]

Tichy, E.D. et al. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev. 19, 1699–1711 (2010). 10.1089/scd.2010.0058

[30]

Hacein-Bey-Abina, S. et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255–256 (2003). 10.1056/nejm200301163480314

[31]

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

Baohui Chen, Luke A. Gilbert, Beth A. Cimini et al.

Cell 2013 10.1016/j.cell.2013.12.001

[32]

DNA targeting specificity of RNA-guided Cas9 nucleases

Patrick D Hsu, David A Scott, Joshua A Weinstein et al.

Nature Biotechnology 2013 10.1038/nbt.2647

[33]

Strogantsev, R. et al. Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression. Genome Biol. 16, 112 (2015). 10.1186/s13059-015-0672-7

[34]

Pettitt, S.J. et al. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat. Methods 6, 493–495 (2009). 10.1038/nmeth.1342

[35]

A hyperactive piggyBac transposase for mammalian applications

Kosuke Yusa, Liqin Zhou, Meng Amy Li et al.

Proceedings of the National Academy of Sciences 2011 10.1073/pnas.1008322108

[36]

Moreno-Mateos, M.A. et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat. Methods 12, 982–988 (2015). 10.1038/nmeth.3543

[37]

Hill, J.T. et al. Poly peak parser: method and software for identification of unknown indels using sanger sequencing of polymerase chain reaction products. Dev. Dyn. 243, 1632–1636 (2014). 10.1002/dvdy.24183

[38]

Platt, R.J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440–455 (2014). 10.1016/j.cell.2014.09.014

Cited By

1,496

Programmable genome editing in human cells using RNA-guided bridge recombinases

Oana Pelea, András Tálas · 2026

Science

Transgene integration in mammalian cells: The tools, the challenges, and the future

John H.C. Fong, Francesca Ceroni · 2025

Cell Systems

Non-viral intron knock-ins for targeted gene integration into human T cells and for T-cell selection

Theodore L. Roth, Johnathan Lu · 2025

Nature Biomedical Engineering

Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase

Isaac P. Witte, George D. Lampe · 2025

Science

The hidden risks of CRISPR/Cas: structural variations and genome integrity

Clotilde Aussel, Toni Cathomen · 2025

Nature Communications

Modulation of the microhomology-mediated end joining pathway suppresses large deletions and enhances homology-directed repair following CRISPR-Cas9-induced DNA breaks

Baolei Yuan, Chongwei Bi · 2024

BMC Biology

Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations

Grégoire Cullot, Eric J. Aird · 2024

Nature Biotechnology

Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model of Parkinson’s disease

Désirée Böck, Maria Wilhelm · 2024

eLife

Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model of Parkinson’s disease

Désirée Böck, Maria Wilhelm · 2024

eLife

A highly efficient transgene knock-in technology in clinically relevant cell types

Alexander G. Allen, Samia Q. Khan · 2023

Nature Biotechnology

Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases

George D. Lampe, Rebeca T. King · 2023

Nature Biotechnology

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing

Jianli Tao, Daniel E. Bauer · 2023

Nature Communications

Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity

Monica E. Neugebauer, Alvin Hsu · 2022

Nature Biotechnology

Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome

Matthew G. Durrant, Alison Fanton · 2022

Nature Biotechnology

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

Chang Li, Aphrodite Georgakopoulou · 2021

Blood Advances

In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model

Chang Li, Hongjie Wang · 2021

Molecular Therapy

DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing

Chaoyou Xue, Eric C. Greene · 2021

Trends in Genetics

Interrogating immune cells and cancer with CRISPR-Cas9

Frank A. Buquicchio, Ansuman T. Satpathy · 2021

Trends in Immunology

CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations

Siyu Chen, Wanhua Xie · 2020

Molecular Therapy - Nucleic Acids

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease

Martijn P.T. Ernst, Mike Broeders · 2020

Molecular Therapy - Methods & C...

Metrics

1,496

Citations

38

References

Details

Published: Jul 16, 2018
Vol/Issue: 36(8)
Pages: 765-771
License: View

Authors

Cite This Article

Michael Kosicki, Kärt Tomberg, Allan Bradley (2018). Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nature Biotechnology, 36(8), 765-771. https://doi.org/10.1038/nbt.4192

Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements

You May Also Like